B-Myb is a highly conserved vertebrate member of the Myb transcription factor family, which is expressed in virtually all proliferating cells. A large body of evidence suggests that B-Myb plays an important role in cell cycle regulation; however, the exact nature of its function has not yet been clarified. We have used gene targeting in chicken DT40 cells, a cell line exhibiting very high rates of homologous recombination, to create cells expressing endogenous B-myb in a doxycyclin-dependent manner. We find that the cells proliferate well in the absence of B-Myb, suggesting that B-Myb is not essential for cell proliferation per se. However, cells lacking B-Myb are more sensitive to DNA-damage induced by UV-irradiation and alkylation. Our work provides the first direct evidence for a novel function of B-Myb in the response to DNA-damage. The cells described here should be a useful model to characterize this function in more detail.
Introduction
The vertebrate Myb family of transcription factors consists of three members, A-Myb, B-Myb and c-Myb. A-Myb and c-Myb have specialized functions in spermatogenic cells and immature haematopoietic cells, respectively. These functions are mirrored by the phenotypes of knockout mice: disruption of c-myb causes defects of fetal hematopoiesis and embryonic death and A-myb knockout mice are infertile due to defective spermatogenesis (Mucenski et al., 1991; Toscani et al., 1997) . By contrast, B-Myb appears to play a more general role in the cell cycle of all proliferating cells (for a review see Joaquin and Watson, 2003) . In the mouse embryo, B-Myb is expressed in virtually all dividing tissues whereas nonproliferating cells lack B-Myb expression (Sitzmann et al., 1996) . B-myb knockout mice show proliferation defects of the cells of the inner cell mass of the blastocyst causing early embryonic death (Tanaka et al., 1999) . B-myb transcription peaks at the late G1/early S phase of the cell cycle (Lam and Watson, 1993) ; in addition, the activity of B-Myb is controlled by post-translational modification and interaction with other proteins. Notably, phosphorylation of B-Myb by cyclin A/Cdk2 stimulates the transactivation potential of B-Myb by relieving repressive effects exerted by the C-terminus of the protein (Lane et al., 1997; Ziebold et al., 1997) . Several B-Myb target genes have been identified, such as the bcl-2, apolipoprotein J, cdc2 and cyclin A and B genes, suggesting a crucial role of B-Myb in cell cycle regulation and control of apoptosis (Grassilli et al., 1999; Zhu et al., 2004; Lang et al., 2005) . In addition, there is evidence that B-Myb may exert some of its functions independently of its transcriptional activity. For example, B-Myb has been shown to overcome a G1 cell cycle block imposed by p107 apparently independent of the activation of specific target genes (Joaquin et al., 2002) . However, although these and other findings collectively suggest an important role in the cell cycle no clear picture of the function of B-Myb has emerged yet.
The chicken DT40 cell line is an extremely useful model to study gene function by targeted gene disruption because homologous recombination occurs at very high frequencies in these cells (Buerstedde and Takeda, 1991) . We have engineered DT40 cells to express endogenous B-myb in a doxycyclin-dependent manner. Surprisingly, we find that B-myb is not essential for cell proliferation per se; rather, our data suggest a novel function for B-myb in the response to DNA-damage.
Results

Targeted disruption of B-myb
To disrupt one copy of B-myb we transfected DT40 cells with a targeting construct, in which the promoter region and exons 1-6 were replaced by a histidinol resistance cassette. As shown in Figure 1a , homologous recombination of the targeting construct leads to the appearance of a novel 10 kb BglII restriction fragment. Southern blot analysis of one of several histidinol-resistant clones is shown in Figure 1c . To generate DT40 cells expressing B-myb conditionally, we then stably introduced a 'Tet-Off' Tet-VP16 expression vector into the heterozygous B-myb clone. Subsequently, a second targeting construct was transfected in which the B-myb promoter was replaced by the puromycin resistance gene and a promoter cassette containing the minimal CMV promoter and several copies of the Tet-operator (Figure 1b ).
Successful targeting of the second copy of B-myb results in the loss of a 10 kb EcoRI fragment (corresponding to the wild-type (wt) copy of B-myb) and the appearance of a novel 4.4 kb fragment. The analysis of a positive clone, designated as (À/ TRE ), is shown in Figure 1c . The B-myb locus, the targeting constructs and the targeted locus are depicted at the top, middle and bottom, respectively. Exons and the selection cassettes are indicated by black and white boxes. The B-myb promoter and the tet-inducible promoter are marked by black and white arrows, respectively. The probe region is indicated by a white bar and the fragments detected by the probe are shown as black bars. Relevant restriction sites: E (EcoRI), Bg (BglII), Ag (AgeI), X (XhoI) and N (NotI). (c) Southern blot of DT40 wt, (7) and (À/ TRE ) cells. BglII-or EcoRI-digested genomic DNA was hybridized with the probe shown in (a) and (b). (d) RNA from wt DT40 cells and two B-myb (À/ TRE ) clones grown in the absence or presence of 1 mg/ml doxycyclin for three days was analysed by Northern blotting with probes specific for B-myb and S17. (e) Cell lysates from wt DT40 cells and two B-myb (À/ TRE ) clones grown for three days in the absence or presence of different amounts of doxycyclin were analysed by Western blotting using B-Myb specific antibodies. Numbers at the bottom indicate the concentration (mg/ml) of doxycyclin B-Myb D Ahlbory et al targeted in the first round of recombination (see Figure 1a ). The 4 kb EcoRI band is due to hybridization of the probe with a downstream fragment. Of three independent B-myb (À/ TRE ) clones two (clones 5 and 62) were studied further.
To confirm doxycyclin-dependent downregulation of B-myb expression RNA isolated from B-myb (À/ TRE ) clones and wt cells was analysed by Northern blotting. Figure 1d shows that the amount of B-myb mRNA in wt cells was not affected by doxycyclin whereas it was detected in the (À/ TRE ) clones only in the absence of doxycyclin. Western blotting showed that B-Myb was only detectable in the (À/ TRE ) clones in the absence of doxycyclin (Figure 1e ). By contrast, wt cells showed no effect of doxycyclin on the amount of B-Myb. We used a concentration of 1 mg/ml of doxycyclin for most subsequent experiments; however, it is evident that even lower concentrations effectively downregulate B-Myb expression. We conclude from the data shown in Figure 1 that we have successfully inactivated one copy of the endogenous B-myb and converted the other copy to a conditional form. Since these results were unexpected, we wondered whether B-Myb expression remains undetectable after prolonged growth in the presence of doxycyclin or whether the levels of A-Myb or c-Myb increase over time to compensate for the lack of B-Myb. To address this issue, we cultivated B-myb (À/ TRE ) for 10 weeks either in the presence or absence of doxycyclin. As doxycylin has a short half-life in tissue culture, fresh doxycyclin was added on a regular basis to keep the concentration around 1 mg/ml at all times. The cells were then analysed by Northern blotting ( Figure 2d ). As shown in Figure 2d , even after continuous cultivation of the cells in the presence of doxycyclin there was no obvious upregulation of B-myb mRNA. Furthermore, the levels of A-myb and c-myb mRNA were affected only slightly.
To identify gene expression changes induced in B-myb (À/ TRE ) cells by doxycyclin, we analysed mRNA from these cells using chicken cDNA microarrays that represent approximately 2200 individual genes (Neiman et al., 2001) . cDNA probes labelled with Cy3 and Cy5 were prepared using RNA from B-myb (À/ TRE ) cells grown for 3 days with or without doxycyclin and hybridized in appropriate combinations to separate microarrays to generate dye-reversed replicate data sets. The position of each dot in the diagram shown in Figure 4 reflects the difference in expression of the corresponding gene in the absence or presence of B-Myb as determined by dye-reversed hybridization experiments. Surprisingly, there were no reproducible gene expression changes greater than twofold (such changes would appear as dots in areas 'a' and 'c'). Some of the genes close to areas 'a' and 'c' were analysed individually by Northern blotting; however, no significant effects of B-Myb on their expression were observed (data not shown). The positions of several putative B-Myb target genes are indicated in Figure 4 . None of these genes, 
DT40 cells lacking B-Myb show increased sensitivity to DNA-damage
Since there were no obvious effects of doxycyclin on B-myb (À/ TRE ) cells under normal growth conditions, we considered the possibility that B-Myb may be required only under certain circumstances. In particular, we were interested to know if B-Myb plays a role in the response to DNA-damage. DT40 wt and B-myb (À/ TRE ) cells kept in the presence or absence of doxycyclin were irradiated with UV-light. Identical numbers of cells were then cultivated with or without doxycyclin and the number of viable cells was determined three days later. Figure 5a shows that B-myb (À/ TRE ) cells were more sensitive to UV-irradiation in the presence than in the absence of doxycyclin while wt cells were not affected by doxycyclin. This suggests that B-Myb may play a role in the response to UV-induced DNA-damage. Figure 5e shows a representative growth curve of DT40 wt and B-myb (À/ TRE ) cells following UV irradiation. The increase of the cell numbers in all cases excludes the possibility that the B-myb (À/ TRE ) cells simply die faster in the presence of doxycyclin than in its absence and demonstrates that there is a difference in survival of these cells in the presence or absence of doxycyclin.
We also measured the number of cells that undergo apoptosis after UV-irradiation. wt and B-myb (À/ TRE ) cells grown in the presence or absence of doxycyclin were UV-irradiated and cultivated for 8 h. Apoptotic cells were then quantified by annexin V staining using a flow cytometer. As control, cells were also analysed without UV-irradiation. Figure 5f shows that small numbers of apoptotic cells were detected in all the Finally, we were interested to know whether the absence of B-Myb also affects the response to other agents causing DNA-damage. Methyl methanesulfonate (MMS), a DNA alkylating agent, had a similar effect on B-myb (À/ TRE ) cells as UV-irradiation (Figure 5c ). Enhanced sensitivity towards DNA damage was, however, not generally observed in cells lacking B-Myb. Etoposide, which induces DNA breaks via topoisomerase II inhibition, had similar effects in DT40 wt and B-myb (À/ TRE ) cells (Figure 5d ).
Discussion
B-Myb is a cell cycle-regulated transcription factor, which is thought to play a key role in the cell cycle of vertebrate cells. Despite recent progress in understanding how B-Myb expression and activity is regulated and the identification of several putative B-Myb target genes the role of B-Myb in proliferating cells is not yet well understood. To explore the function of B-Myb, we have used the chicken DT40 cell line as a model to generate cells in which the level of endogenous B-Myb can be regulated by doxycyclin. Surprisingly, the absence of B-Myb does not affect the proliferation of DT40 cells or the expression of a set of 2200 different chicken genes, including the putative B-Myb target genes, bcl-2, apo J, and the cyclin A and B genes. Our results therefore clearly demonstrate that B-Myb, contrary to the current view, is not an essential component of the cell cycle machinery and does not contribute to the expression of these genes, at least in DT40 cells.
How can our data be reconciled with the previously published observation that B-Myb deficient mice are very early embryonic lethals (Tanaka et al., 1999) ? On one hand, since the molecular basis of embryonic lethality in these mice has not been clarified, it remains possible that B-Myb plays a crucial role early in embryonic development, which is unrelated to cell proliferation. It is also possible that the requirement of B-Myb for cell proliferation differs between early embryonic and more differentiated cells. In this respect, it is interesting to note that embryonic stem cell lines express B-Myb at much higher levels than other proliferating cells (Kamano et al., 1995) . On the other hand, we cannot completely exclude the possibility that the Tet-responsive promoter shows some leakiness in the absence of Tet-VP16 and that the B-myb (À/ TRE ) cells described here therefore have a residual level of B-Myb expression, which is below the limit of detection but which, nevertheless, affects the behaviour of the cells. We also cannot rigorously exclude the possibility that other Myb family members, such as c-Myb or A-Myb, can compensate the loss of B-Myb to some extent, thus providing a possible explanation for the absence of overt effects of B-Myb on cell proliferation and gene expression. Such an explanation is, however, difficult to reconcile with the completely divergent phenotypes of the different myb knockout mice or the different biochemical properties of A-Myb, B-Myb and c-Myb. For example, c-Myb, unlike B-Myb, is not regulated by cell cycle-dependent phosphorylation, making it unlikely that c-Myb can functionally replace B-Myb. In fact, some of the alleged B-Myb target genes, such as the cyclin A and B genes, have been shown not to be targets of c-Myb (Zhu et al., 2004) . A further argument for a unique function of B-Myb is provided by recent work on Drosophila melanogaster. Drosophila has a single myb gene (Dm-myb) that has been implicated in cell proliferation and in controlling the activity of certain origins of DNA replication (Katzen et al., 1998; Beall et al., 2002; Fitzpatrick et al., 2002) . Recent work has shown that B-myb, but not A-myb or c-myb, is able to complement a defective Dm-myb gene (Davidson et al., 2004) , suggesting a unique and probably ancestral function for B-myb, which cannot be complemented by other vertebrate myb family members.
We have made the intriguing observation that cells lacking B-Myb survive DNA-damage induced by UVirradiation and alkylating agents less well than cells expressing B-Myb. Our work, therefore, provides the first direct evidence suggesting a role for B-Myb in the response to DNA-damage rather than in cell proliferation per se.
The DT40 cell line is remarkable for its persistent high frequency of immunoglobulin gene conversion, which is typical of immature B-cells in chickens but not mice or humans. It is therefore possible that the role of B-Myb DNA-damage repair might be more extensive than is evident from our data because certain aspects of DNAdamage repair might be masked in these cells due to the hyperreactivity of homologous recombination.
It is interesting to note that Drosophila Dm-myb mutants accumulate chromosomal abnormalities , implicating Dm-myb in the maintenance of genomic stability. Furthermore, one of the proteins interacting with B-Myb, poly-(ADP-ribose) polymerase (PARP) , has also been implicated in maintaining genomic stability (Huber et al., 2004) , thus providing another potential link between B-Myb and DNA-damage response. How B-Myb acts in response to DNA damage remains to be explored. In light of the apparent functional similarities between B-Myb and Dm-Myb it will be interesting to see whether B-Myb only modulates transcriptional processes or whether it might also have nontranscriptional functions involved in the control of DNA replication processes.
Materials and methods
Targeting constructs
The B-myb targeting vector pBMKO-his-rev was generated by cloning a 2.5 kb EcoRI/BglII fragment from the B-myb upstream region and a 0.6 kb BglII/NotI fragment from the intron between exons 6 and 7 between the EcoRI and NotI sites of pbluescript. The histidinol resistance cassette was then inserted at the BglII site between the two genomic fragments. Homologous recombination of the targeting construct with B-myb will delete the B-myb promoter and exons 1-6 of the gene. To create a tetracycline-inducible copy of B-myb the short arm of the construct described above was replaced by an AgeI/ NotI fragment spanning exons 4-6, the AgeI site being located in exon 4. Upstream of the AgeI site we inserted a XhoI/AgeI fragment that was derived from a plasmid containing the chicken B-myb coding region under the control of a tetracyclineresponsive minimal CMV promoter (pTRE-B-Myb). Finally, the histidinol-resistance cassette was replaced by a puromycinresistance cassette. The resulting targeting construct (pBMKO-TRE-B-myb-puro-rev) will replace the B-myb promoter and exon 1-3 by the tetracycline-responsive promoter and B-myb cDNA sequences to restore the complete B-myb coding region.
Growth curves and cell viability measurements
Growth curves were determined by seeding cells at the desired concentration and counting them at the indicated time points with a haemacytometer. Viable cells were identified by Trypan blue exclusion.
DNA-transfection and blotting
DT40 cells were grown, transfected and analysed by Southern blotting as described (Appl and Klempnauer, 2002) . Polyadenylated RNA was prepared using oligo-dT cellulose (Klempnauer and Bishop, 1983) and chicken B-myb, A-myb and c-myb mRNA, and B-Myb protein was detected as described (Foos et al., 1992 (Foos et al., , 1994 .
Induction of DNA-damage UV-irradiation was performed as described (Appl and Klempnauer, 2002 ) at 25-50 J/m 2 . Methyl methanesulfonate (MMS) was used at a final concentration of 20 mM. Etoposide was used at concentrations between 10 and 100 nM. Cells were cultivated in the presence of the drugs for prolonged times (usually 2 days) until they were split. Caffeine was used and 1 mM final concentration. Cells to be subjected to DNA-damage in the presence of doxycyclin were cultivated for 48-72 h in the presence of doxycyclin before initiating DNA-damage.
Flow cytometry
Cell cycle analysis was performed as described (Appl and Klempnauer, 2002) , using a FACScan flow cytometer (Becton Dickinson). Apoptotic cells were quantified with a flow cytometer after staining with annexin V-FITC as described previously (Lang et al., 2002) . Briefly, cells were labelled after UV-irradiation with annexin V-FITC (BD Pharmingen) in staining buffer (PBS containing Ca 2 þ and Mg 2 þ , 0.05% FCS; 0.5 mg/ml NaN 3 ) for 20 min on ice. Cells were then washed with PBS and subjected to flow cytometry using a FACScan flow cytometer. There was also a low number (2-4%) of necrotic cells, as determined by staining with propidium iodide, in all samples.
Microarray hybridizations
Microarray hybridizations were performed as described (Neiman et al., 2001) .
